Liu Yuqiao, Fan Yue, Liu Jibin, Liu Xiyang, Li Xiuyan, Hu Jingqing
College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xin-Huangpu Joint Innovation Institute of Chinese Medicine, Guangzhou, China.
Front Pharmacol. 2024 Nov 13;15:1499602. doi: 10.3389/fphar.2024.1499602. eCollection 2024.
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver condition closely associated with metabolic syndrome, with its incidence rate continuously rising globally. Recent studies have shown that the development of NAFLD is associated with insulin resistance, lipid metabolism disorder, oxidative stress and endoplasmic reticulum stress. Therapeutic strategies for NAFLD include lifestyle modifications, pharmacological treatments, and emerging biological therapies; however, there is currently no specific drug to treat NAFLD. However Chinese herb medicine (CHM) has shown potential in the treatment of NAFLD due to its unique therapeutic concepts and methods for centuries in China. This review aims to summarize the pathogenesis of NAFLD and some CHMs that have been shown to have therapeutic effects on NAFLD, thus enriching the scientific connotation of TCM theories and facilitating the exploration of TCM in the treatment of NAFLD.
非酒精性脂肪性肝病(NAFLD)是一种与代谢综合征密切相关的慢性肝脏疾病,其发病率在全球范围内持续上升。最近的研究表明,NAFLD的发展与胰岛素抵抗、脂质代谢紊乱、氧化应激和内质网应激有关。NAFLD的治疗策略包括生活方式改变、药物治疗和新兴的生物疗法;然而,目前尚无治疗NAFLD的特效药物。然而,由于其在中国数百年独特的治疗理念和方法,中草药(CHM)在NAFLD的治疗中已显示出潜力。本综述旨在总结NAFLD的发病机制以及一些已显示对NAFLD有治疗作用的中草药,从而丰富中医理论的科学内涵,并促进中医在NAFLD治疗方面的探索。